Douglas Carr

VP, Finance & Operations at Century Therapeutics

Douglas Carr is Vice President of Finance and Operations at Century Therapeutics. Prior to joining Century, he was VP of Finance at Novira Therapeutics, Inc., where he directed all financial and fiscal management aspects of the Company’s operations and played a key role in the sale of the Company to J&J in December 2015. Before Novira, he was Financial Controller for Omthera Pharmaceuticals, Inc. where he established the finance and accounting infrastructure and led the Company through an initial public offering and subsequent sale to Astra Zeneca in 2013. Prior to Omthera, Douglas spent 15 years at Merck primarily providing financial leadership to various commercial franchises. He began his career at PriceWaterhouseCoopers (previously Coopers&Lybrand). Douglas holds a BA from Rutgers University and is a Certified Public Accountant in the State of New Jersey. He currently serves on the Board of Directors at Heritage Conservancy in Doylestown, Pennsylvania.

Links

Previous companies

PwC logo
Merck logo

Timeline

  • VP, Finance & Operations

    Current role

View in org chart